Alhusban, Ahmed et al
"Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis." Journal of Pharmacology and Experimental Therapeutics
350.3
(2014):
635-645.
Web. 23 April. 2024.